 |
Diabetes group urges caution on AvandiaThe latest studies on Avandia, GlaxoSmithKline's blockbuster diabetes drug, have raised enough questions about the drug's safety to worry the American Diabetes Association. Several studies now suggest the drug, which lowers blood sugar lev More… |
Monday 23 December 2024
